| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Linear nevus sebaceous | 1.55e-06 | 3 | 60 | 3 | HP:0010817 | |
| HumanPheno | Increased head circumference | MYCN KRAS CACNA1E PSAP NRAS APC PEX6 HUWE1 SEC24D ZNF469 TONSL HRAS WDR35 PEX5 UHRF1 ANKRD17 NODAL CSGALNACT1 | 9.65e-06 | 500 | 60 | 18 | HP:0040194 |
| HumanPheno | Nevus sebaceous | 1.53e-05 | 5 | 60 | 3 | HP:0010815 | |
| HumanPheno | Abnormality of globe location | MYCN KRAS RAP1B NRAS POLR2A APC PEX6 HUWE1 MED13L TRIP13 SLC32A1 EDEM3 FREM2 SEC24D ASNS TONSL ATXN3 HRAS MED12L WDR35 PEX5 UHRF1 ANKRD17 POLR1B NODAL CSGALNACT1 TARS1 EPB41L1 | 1.84e-05 | 1122 | 60 | 28 | HP:0100886 |
| HumanPheno | Hypertelorism | MYCN KRAS RAP1B NRAS POLR2A APC PEX6 HUWE1 MED13L SLC32A1 EDEM3 FREM2 SEC24D ASNS TONSL HRAS MED12L WDR35 PEX5 UHRF1 POLR1B TARS1 EPB41L1 | 3.05e-05 | 830 | 60 | 23 | HP:0000316 |
| HumanPheno | Macrocephaly | MYCN KRAS CACNA1E NRAS APC PEX6 HUWE1 SEC24D ZNF469 TONSL HRAS WDR35 PEX5 UHRF1 ANKRD17 NODAL CSGALNACT1 | 3.08e-05 | 491 | 60 | 17 | HP:0000256 |
| HumanPheno | Fetal neck anomaly | 3.93e-05 | 111 | 60 | 8 | HP:0025667 | |
| HumanPheno | Abnormal external nose morphology | MYCN KRAS RAP1B NRAS ZNF423 APC PEX6 SIK1 HUWE1 MED13L TRIP13 SLC32A1 EDEM3 FREM2 CHD5 ASNS TONSL HRAS MED12L WDR35 PEX5 ANKRD17 NODAL CSGALNACT1 | 4.83e-05 | 916 | 60 | 24 | HP:0010938 |
| HumanPheno | Slanting of the palpebral fissure | MYCN KRAS RAP1B NRAS SZT2 APC PEX6 HUWE1 MED13L TRIP13 SLC32A1 EDEM3 SEC24D CHD5 HRAS MED12L WDR35 PEX5 ANKRD17 POLR1B CSGALNACT1 | 5.50e-05 | 739 | 60 | 21 | HP:0200006 |
| HumanPheno | Abnormal morphology of the nasal alae | MYCN KRAS NRAS ZNF423 APC PEX6 SIK1 HUWE1 SLC32A1 EDEM3 FREM2 TONSL HRAS MED12L WDR35 PEX5 ANKRD17 NODAL CSGALNACT1 | 7.78e-05 | 639 | 60 | 19 | HP:0000429 |
| HumanPheno | Abnormal nasal tip morphology | MYCN RAP1B NRAS APC HUWE1 MED13L EDEM3 FREM2 CHD5 ASNS TONSL HRAS MED12L CSGALNACT1 | 1.12e-04 | 386 | 60 | 14 | HP:0000436 |
| HumanPheno | Triangular face | 1.24e-04 | 167 | 60 | 9 | HP:0000325 | |
| HumanPheno | Abnormality of globe location or size | MYCN KRAS RAP1B NRAS POLR2A APC PEX6 HUWE1 MED13L TRIP13 SLC32A1 EDEM3 FREM2 SEC24D ASNS TONSL ATXN3 HRAS MED12L WDR35 PEX5 UHRF1 ANKRD17 POLR1B NODAL CSGALNACT1 TARS1 EPB41L1 | 1.37e-04 | 1246 | 60 | 28 | HP:0000489 |
| HumanPheno | Megalencephaly | 1.46e-04 | 44 | 60 | 5 | HP:0001355 | |
| HumanPheno | Frontal bossing | KRAS NRAS SZT2 POLR2A APC PEX6 HUWE1 MED13L TRIP13 SEC24D CHD5 TONSL HRAS MED12L WDR35 PEX5 POLR1B PLA2G6 CSGALNACT1 EPB41L1 | 1.75e-04 | 738 | 60 | 20 | HP:0002007 |
| HumanPheno | Functional intestinal obstruction | 1.76e-04 | 10 | 60 | 3 | HP:0005249 | |
| HumanPheno | High forehead | KRAS NRAS SZT2 POLR2A APC PEX6 HUWE1 TRIP13 MED12L WDR35 PEX5 EPB41L1 | 1.83e-04 | 306 | 60 | 12 | HP:0000348 |
| HumanPheno | Hemihypertrophy | 1.83e-04 | 25 | 60 | 4 | HP:0001528 | |
| HumanPheno | Abnormal shape of the frontal region | KRAS NRAS SZT2 POLR2A APC PEX6 HUWE1 MED13L TRIP13 SEC24D CHD5 TONSL HRAS MED12L WDR35 PEX5 POLR1B PLA2G6 CSGALNACT1 EPB41L1 | 1.86e-04 | 741 | 60 | 20 | HP:0011218 |
| HumanPheno | Abnormal frontal bone morphology | KRAS NRAS SZT2 POLR2A APC PEX6 HUWE1 MED13L TRIP13 SEC24D CHD5 TONSL HRAS MED12L WDR35 PEX5 POLR1B PLA2G6 CSGALNACT1 EPB41L1 | 1.89e-04 | 742 | 60 | 20 | HP:0430000 |
| HumanPheno | Abnormality of calvarial morphology | MYCN KRAS NRAS SZT2 ZNF423 POLR2A APC PEX6 HUWE1 MED13L CR2 TRIP13 FREM2 SEC24D CHD5 TONSL HRAS MED12L WDR35 PEX5 ANKRD17 POLR1B PLA2G6 CSGALNACT1 TARS1 EPB41L1 | 2.04e-04 | 1134 | 60 | 26 | HP:0002648 |
| HumanPheno | Epidermal nevus | 3.17e-04 | 12 | 60 | 3 | HP:0010816 | |
| HumanPheno | Congenital abnormal hair pattern | KRAS NRAS APC PEX6 HUWE1 MED13L SLC32A1 EDEM3 FREM2 HRAS ANKRD17 POLR1B | 3.40e-04 | 327 | 60 | 12 | HP:0011361 |
| HumanPheno | Micrognathia | MYCN KRAS ERBB3 RAP1B NRAS APC PEX6 HUWE1 TRIP13 SEC24D CHD5 ASNS TONSL HRAS WDR35 PEX5 UHRF1 POLR1B PLA2G6 CSGALNACT1 TARS1 | 3.76e-04 | 843 | 60 | 21 | HP:0000347 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | MYCN KRAS ERBB3 RAP1B NRAS APC PEX6 HUWE1 TRIP13 SEC24D CHD5 ASNS TONSL HRAS WDR35 PEX5 UHRF1 POLR1B PLA2G6 CSGALNACT1 TARS1 | 3.89e-04 | 845 | 60 | 21 | HP:0009118 |
| HumanPheno | Nevus spilus | 4.06e-04 | 3 | 60 | 2 | HP:0025510 | |
| HumanPheno | Abnormal calvaria morphology | MYCN KRAS NRAS SZT2 ZNF423 POLR2A APC PEX6 HUWE1 MED13L CR2 TRIP13 PLEKHM1 FREM2 SEC24D CHD5 TONSL HRAS MED12L WDR35 PEX5 ANKRD17 POLR1B PLA2G6 CSGALNACT1 TARS1 EPB41L1 | 4.22e-04 | 1254 | 60 | 27 | HP:0002683 |
| HumanPheno | Transitional cell carcinoma of the bladder | 4.32e-04 | 31 | 60 | 4 | HP:0006740 | |
| HumanPheno | Abnormal shape of the occiput | 4.41e-04 | 119 | 60 | 7 | HP:0011217 | |
| HumanPheno | Depressed nasal bridge | MYCN KRAS RAP1B NRAS PEX6 SIK1 HUWE1 MED13L SLC32A1 FREM2 TONSL HRAS MED12L WDR35 PEX5 UHRF1 CSGALNACT1 | 4.79e-04 | 612 | 60 | 17 | HP:0005280 |
| HumanPheno | Flattened nasal bridge | MYCN KRAS RAP1B NRAS PEX6 SIK1 HUWE1 MED13L SLC32A1 FREM2 TONSL HRAS MED12L WDR35 PEX5 UHRF1 CSGALNACT1 | 4.79e-04 | 612 | 60 | 17 | HP:0000425 |
| HumanPheno | Midface retrusion | KRAS RAP1B NRAS MED13L SEC24D TONSL WDR35 ANKRD17 POLR1B CSGALNACT1 EPB41L1 | 4.85e-04 | 291 | 60 | 11 | HP:0011800 |
| HumanPheno | Abnormal occipital bone morphology | 4.88e-04 | 121 | 60 | 7 | HP:0012294 | |
| HumanPheno | Epicanthus | MYCN KRAS RAP1B NRAS PEX6 HUWE1 MED13L TRIP13 EDEM3 ZNF469 CHD5 TONSL HRAS WDR35 PEX5 UHRF1 TARS1 | 4.97e-04 | 614 | 60 | 17 | HP:0000286 |
| HumanPheno | Hemimegalencephaly | 5.16e-04 | 14 | 60 | 3 | HP:0007206 | |
| HumanPheno | Anteverted nares | MYCN KRAS NRAS ZNF423 APC PEX6 SIK1 HUWE1 SLC32A1 TONSL HRAS MED12L WDR35 PEX5 NODAL CSGALNACT1 | 5.28e-04 | 559 | 60 | 16 | HP:0000463 |
| HumanPheno | Upturned nose | MYCN KRAS NRAS ZNF423 APC PEX6 SIK1 HUWE1 SLC32A1 TONSL HRAS MED12L WDR35 PEX5 NODAL CSGALNACT1 | 5.28e-04 | 559 | 60 | 16 | HP:0000427 |
| HumanPheno | Bladder carcinoma | 5.51e-04 | 33 | 60 | 4 | HP:0002862 | |
| HumanPheno | Thickened nuchal skin fold | 5.89e-04 | 59 | 60 | 5 | HP:0000474 | |
| HumanPheno | Abnormality of the forehead | MYCN KRAS NRAS SZT2 POLR2A APC PEX6 SIK1 HUWE1 MED13L TRIP13 SLC32A1 FREM2 SEC24D CHD5 ASNS TONSL HRAS MED12L WDR35 PEX5 ANKRD17 POLR1B PLA2G6 CSGALNACT1 EPB41L1 | 5.90e-04 | 1208 | 60 | 26 | HP:0000290 |
| HumanPheno | Genu recurvatum | 6.20e-04 | 34 | 60 | 4 | HP:0002816 | |
| HumanPheno | Bladder neoplasm | 6.20e-04 | 34 | 60 | 4 | HP:0009725 | |
| HumanPheno | Aplasia/Hypoplasia involving the nose | MYCN KRAS NRAS APC PEX6 HUWE1 MED13L EDEM3 FREM2 TONSL HRAS PLA2G6 NODAL | 6.20e-04 | 401 | 60 | 13 | HP:0009924 |
| HumanPheno | Follicular hyperplasia | 6.39e-04 | 15 | 60 | 3 | HP:0002729 | |
| HumanPheno | Abnormality of the palpebral fissures | MYCN KRAS RAP1B NRAS SZT2 APC PEX6 HUWE1 MED13L TRIP13 SLC32A1 EDEM3 SEC24D CHD5 HRAS MED12L WDR35 PEX5 ANKRD17 POLR1B CSGALNACT1 | 6.84e-04 | 880 | 60 | 21 | HP:0008050 |
| HumanPheno | Abnormal nostril morphology | MYCN KRAS NRAS ZNF423 APC PEX6 SIK1 HUWE1 SLC32A1 TONSL HRAS MED12L WDR35 PEX5 NODAL CSGALNACT1 | 7.24e-04 | 575 | 60 | 16 | HP:0005288 |
| HumanPheno | Prominent occiput | 7.41e-04 | 62 | 60 | 5 | HP:0000269 | |
| MousePheno | embryonic lethality during organogenesis | MYCN KRAS NRG1 ERBB3 ACACA ESRRB APC ELP1 RAD9B HUWE1 F5 SEC24D PTPRB SLC20A1 SUPV3L1 TONSL WDR35 UHRF1 ANKRD17 DPH3P1 NODAL SMAD1 | 4.67e-06 | 876 | 120 | 22 | MP:0006207 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | MYCN KRAS NRG1 ERBB3 ESRRB APC ELP1 HUWE1 SEC24D PTPRB SLC20A1 SUPV3L1 TONSL WDR35 UHRF1 ANKRD17 DPH3P1 SMAD1 | 2.81e-05 | 700 | 120 | 18 | MP:0011098 |
| MousePheno | abnormal neural tube morphology | MYCN KRAS CCP110 ERBB3 RC3H1 APC ELP1 RAD9B TFRC FREM2 UHRF1 ANKRD17 DPH3P1 NODAL PALLD SMAD1 | 4.45e-05 | 591 | 120 | 16 | MP:0002151 |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 5.98e-07 | 22 | 109 | 5 | M26929 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 1.46e-06 | 26 | 109 | 5 | M29535 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 3.19e-06 | 14 | 109 | 4 | M569 | |
| Pathway | PID_TCR_RAS_PATHWAY | 3.19e-06 | 14 | 109 | 4 | M134 | |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 3.55e-06 | 54 | 109 | 6 | M29742 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 4.45e-06 | 5 | 109 | 3 | M26921 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 5.73e-06 | 16 | 109 | 4 | M562 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 8.84e-06 | 6 | 109 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 8.84e-06 | 6 | 109 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 8.84e-06 | 6 | 109 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 8.84e-06 | 6 | 109 | 3 | M47932 | |
| Pathway | REACTOME_TIE2_SIGNALING | 9.52e-06 | 18 | 109 | 4 | M11932 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 1.20e-05 | 19 | 109 | 4 | M27423 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 1.34e-05 | 40 | 109 | 5 | M62 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 1.54e-05 | 7 | 109 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 1.54e-05 | 7 | 109 | 3 | M19489 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 1.63e-05 | 70 | 109 | 6 | M8232 | |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 2.15e-05 | 44 | 109 | 5 | M175 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 2.45e-05 | 8 | 109 | 3 | M27919 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 2.45e-05 | 8 | 109 | 3 | M47935 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 3.65e-05 | 9 | 109 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 3.65e-05 | 9 | 109 | 3 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 3.65e-05 | 9 | 109 | 3 | M27904 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 4.05e-05 | 50 | 109 | 5 | M553 | |
| Pathway | WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS | 6.92e-05 | 29 | 109 | 4 | M39516 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 7.09e-05 | 11 | 109 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 7.09e-05 | 11 | 109 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 7.09e-05 | 11 | 109 | 3 | M47371 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 7.09e-05 | 11 | 109 | 3 | MM14760 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 7.09e-05 | 11 | 109 | 3 | M27911 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 7.09e-05 | 11 | 109 | 3 | M27740 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 7.09e-05 | 11 | 109 | 3 | M29814 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 7.09e-05 | 11 | 109 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 7.09e-05 | 11 | 109 | 3 | M47432 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 7.09e-05 | 11 | 109 | 3 | MM14533 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 8.34e-05 | 58 | 109 | 5 | M544 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 9.40e-05 | 12 | 109 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 9.40e-05 | 12 | 109 | 3 | M47815 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 9.40e-05 | 12 | 109 | 3 | M29851 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 9.40e-05 | 12 | 109 | 3 | M39408 | |
| Pathway | WP_BDNFTRKB_SIGNALING | 1.16e-04 | 33 | 109 | 4 | M39532 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 1.16e-04 | 33 | 109 | 4 | MM14523 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 1.22e-04 | 13 | 109 | 3 | M47594 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 1.22e-04 | 13 | 109 | 3 | M1441 | |
| Pathway | PID_MAPK_TRK_PATHWAY | 1.31e-04 | 34 | 109 | 4 | M270 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.54e-04 | 14 | 109 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 1.54e-04 | 14 | 109 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.54e-04 | 14 | 109 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 1.54e-04 | 14 | 109 | 3 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.54e-04 | 14 | 109 | 3 | M47378 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 1.54e-04 | 14 | 109 | 3 | M27908 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 1.54e-04 | 14 | 109 | 3 | M27734 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.54e-04 | 14 | 109 | 3 | M47488 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 1.54e-04 | 14 | 109 | 3 | M719 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 1.65e-04 | 36 | 109 | 4 | M271 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 1.91e-04 | 15 | 109 | 3 | M29701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47531 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 2.05e-04 | 70 | 109 | 5 | M3115 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 2.24e-04 | 267 | 109 | 9 | M10792 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47801 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 2.34e-04 | 16 | 109 | 3 | M41733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47682 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 2.34e-04 | 16 | 109 | 3 | M29847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47483 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR2 | 2.49e-04 | 73 | 109 | 5 | M27531 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 2.49e-04 | 40 | 109 | 4 | M27532 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 2.49e-04 | 40 | 109 | 4 | M27557 | |
| Pathway | PID_ER_NONGENOMIC_PATHWAY | 2.49e-04 | 40 | 109 | 4 | M41 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 2.75e-04 | 41 | 109 | 4 | M27533 | |
| Pathway | REACTOME_TIE2_SIGNALING | 2.83e-04 | 17 | 109 | 3 | MM14836 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 2.83e-04 | 17 | 109 | 3 | M47376 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY | 2.83e-04 | 17 | 109 | 3 | M47684 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 2.83e-04 | 17 | 109 | 3 | M27918 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE | 3.31e-04 | 43 | 109 | 4 | M27534 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 3.37e-04 | 18 | 109 | 3 | M27518 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 3.37e-04 | 18 | 109 | 3 | M39737 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 3.37e-04 | 18 | 109 | 3 | M657 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 3.62e-04 | 44 | 109 | 4 | MM14520 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 3.95e-04 | 45 | 109 | 4 | M27623 | |
| Pubmed | Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions. | 1.61e-09 | 5 | 149 | 4 | 34535655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | REXO4 ACACA POLR2A ELP1 HUWE1 ANKHD1 TRIP13 FAM83H TFRC SF3B3 C5orf24 MDN1 DDX50 GGCT SUPV3L1 ASNS ANKRD17 UTP20 POLR1B ALDH9A1 PALLD TARS1 ALOX12B KIF2C | 3.65e-09 | 1353 | 149 | 24 | 29467282 |
| Pubmed | Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth. | 4.82e-09 | 6 | 149 | 4 | 29615452 | |
| Pubmed | Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. | 2.23e-08 | 8 | 149 | 4 | 20150892 | |
| Pubmed | KANSL1L CACNA1E DNAH3 KALRN ICA1 ANKHD1 PLEKHM1 KCNH6 GUCY1A2 NOTCH4 | 7.27e-08 | 233 | 149 | 10 | 37704626 | |
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 7.71e-08 | 3 | 149 | 3 | 28116986 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 7.71e-08 | 3 | 149 | 3 | 19101897 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 33620658 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 22589270 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 7.71e-08 | 3 | 149 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 7.71e-08 | 3 | 149 | 3 | 7776260 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 25788415 | ||
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 7.71e-08 | 3 | 149 | 3 | 26799184 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 7.71e-08 | 3 | 149 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 7.71e-08 | 3 | 149 | 3 | 23240926 | |
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 7.71e-08 | 3 | 149 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 7.71e-08 | 3 | 149 | 3 | 17712732 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 24222113 | ||
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 7.71e-08 | 3 | 149 | 3 | 22945650 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 19303097 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 27911734 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 7.71e-08 | 3 | 149 | 3 | 20150643 | |
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 7.71e-08 | 3 | 149 | 3 | 9334313 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 7.71e-08 | 3 | 149 | 3 | 37013448 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 25977330 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 28630043 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 7.71e-08 | 3 | 149 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 7.71e-08 | 3 | 149 | 3 | 26253102 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 16573741 | ||
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 7.71e-08 | 3 | 149 | 3 | 20090846 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 21737741 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 17943694 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 7.71e-08 | 3 | 149 | 3 | 16761621 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 20971740 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 27119512 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | REXO4 ACACA ICE2 RC3H1 ESRRB APC PUM2 ANKHD1 CPED1 SLIT2 SF3B3 ANKRD17 POLR1B ZMYM1 TXLNG PALLD | 9.93e-08 | 724 | 149 | 16 | 36232890 |
| Pubmed | ACACA APC ANKHD1 ATXN3 ANKRD17 POLR1B MTCL1 LRBA TXLNG GARRE1 | 1.04e-07 | 242 | 149 | 10 | 34011540 | |
| Pubmed | SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. | 1.04e-07 | 11 | 149 | 4 | 28263956 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ACACA KALRN SZT2 POLR2A PEX6 HUWE1 MED13L ANKHD1 PLEKHM1 TBC1D9 FAM83H ITPR3 MDN1 SSH1 CASKIN1 CHD5 NLRC5 PLA2G6 LRBA | 2.91e-07 | 1105 | 149 | 19 | 35748872 |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 10085069 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 38849523 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 9674433 | ||
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 3.07e-07 | 4 | 149 | 3 | 28117393 | |
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 3.07e-07 | 4 | 149 | 3 | 27936046 | |
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 3.07e-07 | 4 | 149 | 3 | 29502968 | |
| Pubmed | Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. | 3.07e-07 | 4 | 149 | 3 | 7972015 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 10490827 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 18372904 | ||
| Pubmed | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 3.07e-07 | 4 | 149 | 3 | 25999467 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 34948093 | ||
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 3.07e-07 | 4 | 149 | 3 | 20080631 | |
| Pubmed | 4.26e-07 | 15 | 149 | 4 | 23831572 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | POLR2A ELP1 HUWE1 TRIP13 F5 FAM83H TFRC ITPR3 SLIT2 SF3B3 MDN1 DDX50 PELP1 SLC20A1 PEX5 UHRF1 UTP20 TARS1 | 4.46e-07 | 1024 | 149 | 18 | 24711643 |
| Pubmed | Novel RFLPs at protooncogene and cancer-related gene loci on mouse chromosomes. | 5.66e-07 | 16 | 149 | 4 | 8095010 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 6.04e-07 | 38 | 149 | 5 | 30786075 | |
| Pubmed | CCP110 TES ICE2 POLR2A ICA1 APC PUM2 HUWE1 TFRC EDEM3 SLC20A1 PEX5 POLR1B ZMYM1 ALDH9A1 | 6.71e-07 | 733 | 149 | 15 | 34672954 | |
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 22982107 | ||
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 16356174 | ||
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 9069260 | ||
| Pubmed | Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. | 7.66e-07 | 5 | 149 | 3 | 24746824 | |
| Pubmed | Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation. | 7.66e-07 | 5 | 149 | 3 | 15558479 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCP110 ACACA TRPM7 GRK7 APC SIK1 GIGYF1 FAM83H MDN1 ANKRD17 MTCL1 PALLD GARRE1 EPB41L1 KIF2C DYRK2 | 9.91e-07 | 861 | 149 | 16 | 36931259 |
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 11173924 | ||
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 19659570 | ||
| Pubmed | EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. | 1.53e-06 | 6 | 149 | 3 | 22975375 | |
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 9753431 | ||
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 21072204 | ||
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 10882715 | ||
| Pubmed | LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. | 1.53e-06 | 6 | 149 | 3 | 31337872 | |
| Pubmed | Erk and MAPK signaling is essential for intestinal development through Wnt pathway modulation. | 1.79e-06 | 47 | 149 | 5 | 32747435 | |
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 20526288 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 20012784 | ||
| Pubmed | Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. | 2.66e-06 | 7 | 149 | 3 | 35904492 | |
| Pubmed | SmgGDS displays differential binding and exchange activity towards different Ras isoforms. | 2.66e-06 | 7 | 149 | 3 | 11948427 | |
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 20860430 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 22199277 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 19487299 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 9488663 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 20179099 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 9690470 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 6641714 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RAP1B REXO4 ACACA POLR2A ELP1 HUWE1 ANKHD1 TRIP13 TFRC MROH8 SF3B3 MDN1 DDX50 PELP1 GGCT SUPV3L1 ASNS UHRF1 UTP20 TARS1 | 3.19e-06 | 1425 | 149 | 20 | 30948266 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ACACA POLR2A APC ELP1 HUWE1 ITPR3 PPP4R3B DDX50 PELP1 ANKRD17 POLR1B | 3.39e-06 | 440 | 149 | 11 | 34244565 |
| Pubmed | USP18 SEMA4D ERBB3 GRK7 RC3H1 POLR2A APC BCL2L2 ADAM12 KCNH6 SSH1 MMP15 TARS1 KCNH5 | 3.41e-06 | 730 | 149 | 14 | 34857952 | |
| Pubmed | ACACA POLR2A ELP1 HUWE1 TRIP13 FAM83H TFRC SF3B3 MDN1 PELP1 ASNS LRBA TARS1 | 4.04e-06 | 638 | 149 | 13 | 33239621 | |
| Pubmed | KRAS CACNA1E KALRN APC DPYSL4 HUWE1 MDN1 SSH1 PELP1 CASKIN1 HRAS PEX5 ANKRD17 MTCL1 EPB41L1 KIF2C | 4.16e-06 | 963 | 149 | 16 | 28671696 | |
| Pubmed | 4.25e-06 | 8 | 149 | 3 | 15064703 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYCN ZBTB2 NRAS MAP3K8 POLR2A HUWE1 ANKHD1 UBA7 C5orf24 MDN1 PELP1 ANKRD17 UTP20 CHSY3 KIF2C | 4.55e-06 | 857 | 149 | 15 | 25609649 |
| Pubmed | ERBB3 APC PEX6 ELP1 GIGYF1 ANKHD1 FREM2 SUPV3L1 TONSL ANKRD17 PALLD GARRE1 EPB41L1 | 4.94e-06 | 650 | 149 | 13 | 38777146 | |
| Pubmed | 6.35e-06 | 9 | 149 | 3 | 10783161 | ||
| Pubmed | 6.35e-06 | 9 | 149 | 3 | 9344703 | ||
| Pubmed | Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. | 6.35e-06 | 9 | 149 | 3 | 16139798 | |
| Pubmed | 9.05e-06 | 10 | 149 | 3 | 34215617 | ||
| Pubmed | 9.05e-06 | 10 | 149 | 3 | 20881644 | ||
| Pubmed | Desmoplakin maintains gap junctions by inhibiting Ras/MAPK and lysosomal degradation of connexin-43. | 9.05e-06 | 10 | 149 | 3 | 29959233 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RAP1B TES ACACA POLR2A ELP1 HUWE1 ANKHD1 ASNS ANKRD17 UTP20 POLR1B LRBA ALDH9A1 | 1.16e-05 | 704 | 149 | 13 | 29955894 |
| Pubmed | CCP110 KALRN APC GIGYF1 HUWE1 PPP4R3B UHRF1 MTCL1 TXLNG PALLD EPB41L1 | 1.19e-05 | 503 | 149 | 11 | 16964243 | |
| Pubmed | 1.20e-05 | 33 | 149 | 4 | 26296893 | ||
| Interaction | SLITRK2 interactions | 3.69e-06 | 5 | 146 | 3 | int:SLITRK2 | |
| Interaction | ELMOD3 interactions | 4.50e-06 | 16 | 146 | 4 | int:ELMOD3 | |
| Interaction | CNOT9 interactions | KRAS CCP110 RC3H1 APC PUM2 GIGYF1 ANKHD1 PEX5 ANKRD17 GARRE1 | 7.32e-06 | 231 | 146 | 10 | int:CNOT9 |
| Interaction | HEPH interactions | 7.33e-06 | 6 | 146 | 3 | int:HEPH | |
| Interaction | SRPK2 interactions | MYCN KRAS ANKRD35 LRRC34 ERBB3 ZBTB2 REXO4 DBF4B RC3H1 POLR2A F5 DDX50 PELP1 MTCL1 PALLD EPB41L1 DYRK2 | 1.78e-05 | 717 | 146 | 17 | int:SRPK2 |
| Interaction | MED4 interactions | KRAS CCP110 POLR2A ESRRB PUM2 HUWE1 MED13L F5 HPX MED12L LRBA TXLNG SMAD1 | 2.48e-05 | 450 | 146 | 13 | int:MED4 |
| Interaction | DNAJA1 interactions | MYCN ERBB3 ZBTB2 TES PSAP ACACA RC3H1 ESRRB HUWE1 ANKHD1 ANKRD55 ATXN3 GARRE1 TARS1 | 3.41e-05 | 533 | 146 | 14 | int:DNAJA1 |
| Interaction | SPRY4 interactions | 3.81e-05 | 86 | 146 | 6 | int:SPRY4 | |
| Interaction | TRPV2 interactions | 4.31e-05 | 10 | 146 | 3 | int:TRPV2 | |
| Interaction | RGL2 interactions | 4.73e-05 | 28 | 146 | 4 | int:RGL2 | |
| Interaction | IRS4 interactions | 5.16e-05 | 290 | 146 | 10 | int:IRS4 | |
| Interaction | ZFP36 interactions | 5.32e-05 | 181 | 146 | 8 | int:ZFP36 | |
| Interaction | FBXW7 interactions | MYCN KRAS TES TRPM7 POLR2A ELP1 HUWE1 MED13L ANKHD1 TRIP13 TFRC SF3B3 GGCT TONSL HRAS UHRF1 TNFRSF19 MTCL1 TARS1 SMAD1 NOTCH4 DYRK2 | 6.38e-05 | 1215 | 146 | 22 | int:FBXW7 |
| Interaction | EIF4ENIF1 interactions | RC3H1 POLR2A PUM2 GIGYF1 ANKHD1 SF3B3 SUPV3L1 ANKRD17 GARRE1 SMAD1 | 6.85e-05 | 300 | 146 | 10 | int:EIF4ENIF1 |
| Interaction | GTSF1 interactions | 7.81e-05 | 12 | 146 | 3 | int:GTSF1 | |
| Interaction | MEAK7 interactions | 8.12e-05 | 32 | 146 | 4 | int:MEAK7 | |
| Interaction | CCDC8 interactions | KRAS POLR2A ELP1 HUWE1 TRIP13 F5 FAM83H ITPR3 SLIT2 SF3B3 MDN1 DDX50 PEX5 UHRF1 UTP20 | 8.58e-05 | 656 | 146 | 15 | int:CCDC8 |
| Interaction | HSPA4L interactions | 8.90e-05 | 250 | 146 | 9 | int:HSPA4L | |
| Interaction | MED6 interactions | 9.39e-05 | 101 | 146 | 6 | int:MED6 | |
| Interaction | CPEB1 interactions | 9.50e-05 | 146 | 146 | 7 | int:CPEB1 | |
| Interaction | OXSM interactions | 1.16e-04 | 35 | 146 | 4 | int:OXSM | |
| Interaction | ITGB6 interactions | 1.28e-04 | 14 | 146 | 3 | int:ITGB6 | |
| Interaction | CTDSP1 interactions | 1.29e-04 | 107 | 146 | 6 | int:CTDSP1 | |
| Interaction | MED26 interactions | 1.29e-04 | 107 | 146 | 6 | int:MED26 | |
| Interaction | FAM83F interactions | 1.30e-04 | 36 | 146 | 4 | int:FAM83F | |
| Interaction | DKKL1 interactions | 1.58e-04 | 111 | 146 | 6 | int:DKKL1 | |
| Interaction | ZNF207 interactions | 1.58e-04 | 111 | 146 | 6 | int:ZNF207 | |
| Interaction | MOV10 interactions | MYCN CCP110 USP18 RAP1B ZBTB2 REXO4 TES ACACA RC3H1 POLR2A PUM2 GIGYF1 ANKHD1 MKNK1 HRAS PEX5 MTCL1 LRBA TXLNG GARRE1 KIF2C DYRK2 | 1.64e-04 | 1297 | 146 | 22 | int:MOV10 |
| Interaction | YWHAQ interactions | MYCN KRAS CCP110 ZBTB2 ACACA TRPM7 RC3H1 ESRRB APC SIK1 GIGYF1 ANKRD55 FAM83H PPP4R3B SLC8A2 SSH1 ANKRD17 LRBA GARRE1 EPB41L1 | 1.67e-04 | 1118 | 146 | 20 | int:YWHAQ |
| Interaction | MARK2 interactions | 1.78e-04 | 274 | 146 | 9 | int:MARK2 | |
| Interaction | SEC13 interactions | 1.82e-04 | 216 | 146 | 8 | int:SEC13 | |
| Interaction | USP32 interactions | 1.83e-04 | 114 | 146 | 6 | int:USP32 | |
| Interaction | PSMA5 interactions | KRAS ERBB3 ACACA POLR2A PUM2 PSMD9 HUWE1 ATXN3 EPB41L1 KIF2C | 1.86e-04 | 339 | 146 | 10 | int:PSMA5 |
| Interaction | SAMSN1 interactions | 1.95e-04 | 16 | 146 | 3 | int:SAMSN1 | |
| Interaction | SHOC2 interactions | 2.01e-04 | 74 | 146 | 5 | int:SHOC2 | |
| Cytoband | 10q22.1 | 1.56e-05 | 46 | 149 | 4 | 10q22.1 | |
| Cytoband | 16p12.3 | 1.86e-04 | 34 | 149 | 3 | 16p12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q22 | 6.13e-04 | 208 | 149 | 5 | chr10q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q15 | 8.19e-04 | 56 | 149 | 3 | chr12q15 | |
| GeneFamily | RAS type GTPase family | 2.78e-05 | 31 | 103 | 4 | 389 | |
| GeneFamily | Ankyrin repeat domain containing | 7.31e-05 | 242 | 103 | 8 | 403 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNA1E TES PCDHB4 APC GIGYF1 MED13L SLC7A14 TBC1D9 SLC32A1 SLC8A2 MDN1 CASKIN1 CHD5 ASNS PLXNA4 CACNA1I CHSY3 CSGALNACT1 EPB41L1 DYRK2 | 4.84e-06 | 1106 | 149 | 20 | M39071 |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP | 1.98e-05 | 200 | 149 | 8 | M9886 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN | 1.98e-05 | 200 | 149 | 8 | M7469 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-08 | 189 | 149 | 9 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | TRPM7 ICA1 ESRRB GRB14 TBC1D9 SLC20A1 TNFRSF19 LRBA CSGALNACT1 | 1.58e-08 | 189 | 149 | 9 | 975c0f079903ae36b0ffa54e86294d42ec7697de |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | TRPM7 ICA1 ESRRB GRB14 TBC1D9 SLC20A1 TNFRSF19 LRBA CSGALNACT1 | 1.58e-08 | 189 | 149 | 9 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-08 | 190 | 149 | 9 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-07 | 195 | 149 | 8 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 1.02e-06 | 157 | 149 | 7 | eb2520c237543ea4869d4386afc0457b111f6193 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-06 | 169 | 149 | 7 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-06 | 173 | 149 | 7 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 177 | 149 | 7 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 177 | 149 | 7 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 180 | 149 | 7 | fc5b9d0e3215652e490ca72d69f776e9725608b2 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 180 | 149 | 7 | 6763b22f2383931c747b37cd0ae2f60b08f64d90 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-06 | 182 | 149 | 7 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 186 | 149 | 7 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 186 | 149 | 7 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 186 | 149 | 7 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-06 | 188 | 149 | 7 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-06 | 189 | 149 | 7 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-06 | 190 | 149 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 191 | 149 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 191 | 149 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.89e-06 | 192 | 149 | 7 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | HSPCs-Mk_prog.|HSPCs / Lineage and Cell class | 4.16e-06 | 194 | 149 | 7 | 5c05d508f5c29e6efe87506bf59e3b0fe5922f65 | |
| ToppCell | ileum-Epithelial_Stem_Cells|ileum / shred on tissue and cell subclass | 4.23e-06 | 126 | 149 | 6 | a8ed48cbd1e207fd1aaad454fda9f329eb22aa83 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-06 | 195 | 149 | 7 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-06 | 195 | 149 | 7 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-06 | 196 | 149 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-06 | 196 | 149 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-06 | 196 | 149 | 7 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-06 | 196 | 149 | 7 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-06 | 196 | 149 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.45e-06 | 196 | 149 | 7 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-06 | 198 | 149 | 7 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.92e-06 | 199 | 149 | 7 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | wk_08-11-Epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.08e-06 | 200 | 149 | 7 | 445fc7995ffc440c6256a6aab0bbf33fb0fea028 | |
| ToppCell | PSB-critical-LOC-Lymphoid-NKT|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.29e-05 | 153 | 149 | 6 | 4d45aa5e3710d5badc13940f14095c1894dbab9d | |
| ToppCell | Myeloid-Myeloid-F|Myeloid / shred on cell class and cell subclass (v4) | 1.44e-05 | 156 | 149 | 6 | d6317843ae5c5749452889e768c187a9d9e8c7fe | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 160 | 149 | 6 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 160 | 149 | 6 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D122|Adult / Lineage, Cell type, age group and donor | 1.66e-05 | 160 | 149 | 6 | 0cfe130606af433b2aa90e0a20b6c44659dd6fd4 | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 167 | 149 | 6 | 2812353ff66e76f10bd327ceb0e6b009502a5258 | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 167 | 149 | 6 | d15168f46c1599d9fc68a05a7b822c4b439f2987 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 2.19e-05 | 168 | 149 | 6 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.19e-05 | 168 | 149 | 6 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D122|Adult / Lineage, Cell type, age group and donor | 2.34e-05 | 170 | 149 | 6 | a99cb3d21f8eb926886340ea99491e078e607648 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 2.50e-05 | 172 | 149 | 6 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 2.58e-05 | 173 | 149 | 6 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.67e-05 | 174 | 149 | 6 | cb0109661e8c9ca04d67d33f2d926f0e649bf67d | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-05 | 177 | 149 | 6 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-05 | 177 | 149 | 6 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-05 | 177 | 149 | 6 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 3.03e-05 | 178 | 149 | 6 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 179 | 149 | 6 | 479116ac65488c60104a053530830763ec1f95b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 179 | 149 | 6 | 1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 179 | 149 | 6 | 69a1b3b05c921de6343ffe6ad998aa2b804312a7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-05 | 179 | 149 | 6 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.22e-05 | 180 | 149 | 6 | 5e78b29fa1cbdcf502fee3577e5b45766b90d1dc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.33e-05 | 181 | 149 | 6 | 13270b6ba6a9c8e5681c6f40000c643ce1d9344a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.33e-05 | 181 | 149 | 6 | 3e3c903b522dced6bec5dc447cc3f8bf9a9749e3 | |
| ToppCell | Healthy/Control-pDC|World / Disease group and Cell class | 3.43e-05 | 182 | 149 | 6 | 97e0eee10905f2cf2bebb09e474629fc224f4397 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-7|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.43e-05 | 182 | 149 | 6 | af16334fec2c757b03c84cf252d00e92fa81e4cd | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 183 | 149 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-05 | 183 | 149 | 6 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-05 | 184 | 149 | 6 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.65e-05 | 184 | 149 | 6 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast|bone_marrow / Manually curated celltypes from each tissue | 3.76e-05 | 185 | 149 | 6 | a62ebaff92f2ed27b27b32c27c89cfbe2cb35116 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-05 | 186 | 149 | 6 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.87e-05 | 186 | 149 | 6 | ffd4510b4435d9bf94c2ef14c629f73ab78c5d93 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 3.87e-05 | 186 | 149 | 6 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.99e-05 | 187 | 149 | 6 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 3.99e-05 | 187 | 149 | 6 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.99e-05 | 187 | 149 | 6 | 03de3c2df31bca0dc4e3718bada708d8fe8b69b9 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 4.11e-05 | 188 | 149 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-05 | 188 | 149 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.11e-05 | 188 | 149 | 6 | c613c6c7b6de8ed514253c9f9b8622c56fcc1452 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.11e-05 | 188 | 149 | 6 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 4.23e-05 | 189 | 149 | 6 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 189 | 149 | 6 | 1be5067c1e45af7d09c1fd6955952cb9e031a3a0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-05 | 189 | 149 | 6 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 189 | 149 | 6 | 30dc1725d43a60017fb12d706f1f85a33de4947e | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-05 | 115 | 149 | 5 | e11128262ba1e2a7053b1b6c039f1aab37d2ce27 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-05 | 190 | 149 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-05 | 190 | 149 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 4.36e-05 | 190 | 149 | 6 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | PND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.36e-05 | 190 | 149 | 6 | 1357bd4527399d7013ee33272bda7453f472999a | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.36e-05 | 190 | 149 | 6 | 5130fb325f80f591b9b36beacb8072c4472304f2 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.36e-05 | 190 | 149 | 6 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.49e-05 | 191 | 149 | 6 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-05 | 191 | 149 | 6 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-05 | 191 | 149 | 6 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | 11.5-Airway-Epithelial-Bud_tip_adjacent|Airway / Age, Tissue, Lineage and Cell class | 4.62e-05 | 192 | 149 | 6 | fbb34a959b9bd9cb72a5195a07f4653a957e4ca8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.62e-05 | 192 | 149 | 6 | 6d7dd35869d86c3e991a61e17825053a3bfab44d | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.76e-05 | 193 | 149 | 6 | 4f38aae346ea3b4258744e9dc1e5aeb4fea13d06 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 149 | 6 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 149 | 6 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 193 | 149 | 6 | dd9874898587fe9fd9cf2aebc2e0579dcf06944e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.76e-05 | 193 | 149 | 6 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 194 | 149 | 6 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 194 | 149 | 6 | f08a7618a9ccf12e4a7620235ae662a8abc521af | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.90e-05 | 194 | 149 | 6 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| Drug | AC1L32OA | 2.11e-07 | 9 | 148 | 4 | CID000107745 | |
| Drug | L 744832 | 1.07e-06 | 4 | 148 | 3 | ctd:C096898 | |
| Disease | Verrucous epidermal nevus | 1.09e-07 | 3 | 142 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 1.09e-07 | 3 | 142 | 3 | C4552097 | |
| Disease | Organoid Nevus Phakomatosis | 1.09e-07 | 3 | 142 | 3 | C0265329 | |
| Disease | Linear nevus sebaceous syndrome | 1.09e-07 | 3 | 142 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 1.09e-07 | 3 | 142 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 1.09e-07 | 3 | 142 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 1.09e-07 | 3 | 142 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 1.09e-07 | 3 | 142 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 1.09e-07 | 3 | 142 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Linear Verrucous Epidermal Nevus | 1.09e-07 | 3 | 142 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 1.09e-07 | 3 | 142 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | NEVUS, EPIDERMAL (disorder) | 1.08e-06 | 5 | 142 | 3 | C0334082 | |
| Disease | Follicular thyroid carcinoma | 1.08e-06 | 5 | 142 | 3 | C0206682 | |
| Disease | Pleocytosis | 2.16e-06 | 6 | 142 | 3 | C0151857 | |
| Disease | Hemimegalencephaly | 2.16e-06 | 6 | 142 | 3 | C0431391 | |
| Disease | Leukocytosis | 2.16e-06 | 6 | 142 | 3 | C0023518 | |
| Disease | Neuroblastoma | 3.14e-06 | 47 | 142 | 5 | C0027819 | |
| Disease | RASopathy (implicated_via_orthology) | 8.97e-06 | 9 | 142 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.28e-05 | 30 | 142 | 4 | DOID:9256 (implicated_via_orthology) | |
| Disease | transitional cell carcinoma (is_marker_for) | 1.35e-05 | 63 | 142 | 5 | DOID:2671 (is_marker_for) | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.66e-05 | 32 | 142 | 4 | DOID:10155 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | KRAS NRG1 ERBB3 KALRN PCDHB15 ELP1 ADAM12 TFRC C5orf34 GUCY1A2 CHD5 HRAS NLRC5 UTP20 OXSM LRBA NOTCH4 | 1.70e-05 | 1074 | 142 | 17 | C0006142 |
| Disease | Noonan Syndrome 1 | 1.75e-05 | 11 | 142 | 3 | C4551602 | |
| Disease | Turner Syndrome, Male | 1.75e-05 | 11 | 142 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 1.75e-05 | 11 | 142 | 3 | C1527404 | |
| Disease | kidney cancer (implicated_via_orthology) | 1.75e-05 | 11 | 142 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | prostate cancer (implicated_via_orthology) | 1.89e-05 | 33 | 142 | 4 | DOID:10283 (implicated_via_orthology) | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 2.30e-05 | 2 | 142 | 2 | 614470 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 2.30e-05 | 2 | 142 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 2.30e-05 | 2 | 142 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 2.30e-05 | 2 | 142 | 2 | 137550 | |
| Disease | Melanocytic nevus | 2.30e-05 | 2 | 142 | 2 | cv:C0027962 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 2.30e-05 | 2 | 142 | 2 | C2674723 | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 2.30e-05 | 2 | 142 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | Large congenital melanocytic nevus | 2.30e-05 | 2 | 142 | 2 | cv:C1842036 | |
| Disease | Adenoma, Microcystic | 2.69e-05 | 36 | 142 | 4 | C0205648 | |
| Disease | Adenoma, Monomorphic | 2.69e-05 | 36 | 142 | 4 | C0205649 | |
| Disease | Adenoma, Basal Cell | 2.69e-05 | 36 | 142 | 4 | C0205646 | |
| Disease | Follicular adenoma | 2.69e-05 | 36 | 142 | 4 | C0205647 | |
| Disease | Papillary adenoma | 2.69e-05 | 36 | 142 | 4 | C0205650 | |
| Disease | Adenoma, Trabecular | 2.69e-05 | 36 | 142 | 4 | C0205651 | |
| Disease | Adenoma | 2.69e-05 | 36 | 142 | 4 | C0001430 | |
| Disease | Colorectal Carcinoma | KRAS DNAH3 NRAS ACACA TCN2 KALRN TRPM7 APC F5 TFRC GUCY1A2 CHD5 NODAL | 3.67e-05 | 702 | 142 | 13 | C0009402 |
| Disease | Lung Neoplasms | 4.53e-05 | 265 | 142 | 8 | C0024121 | |
| Disease | Malignant neoplasm of lung | 4.65e-05 | 266 | 142 | 8 | C0242379 | |
| Disease | RASopathy | 4.76e-05 | 15 | 142 | 3 | cv:C5555857 | |
| Disease | Neoplastic Cell Transformation | 5.93e-05 | 139 | 142 | 6 | C0007621 | |
| Disease | Colorectal Neoplasms | 6.18e-05 | 277 | 142 | 8 | C0009404 | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 6.88e-05 | 3 | 142 | 2 | C1842036 | |
| Disease | Hemangiosarcoma | 8.44e-05 | 18 | 142 | 3 | C0018923 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 9.99e-05 | 19 | 142 | 3 | C3501846 | |
| Disease | Pancreatic carcinoma | 9.99e-05 | 19 | 142 | 3 | C0235974 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 9.99e-05 | 19 | 142 | 3 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 9.99e-05 | 19 | 142 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 9.99e-05 | 19 | 142 | 3 | C0587248 | |
| Disease | leukemia (implicated_via_orthology) | 9.99e-05 | 19 | 142 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | Stomach Carcinoma | 1.36e-04 | 21 | 142 | 3 | C0699791 | |
| Disease | NEVUS, EPIDERMAL | 1.37e-04 | 4 | 142 | 2 | 162900 | |
| Disease | Malignant neoplasm of penis | 1.37e-04 | 4 | 142 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 1.37e-04 | 4 | 142 | 2 | C0030849 | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 1.37e-04 | 4 | 142 | 2 | C4011754 | |
| Disease | BLADDER CANCER | 1.37e-04 | 4 | 142 | 2 | 109800 | |
| Disease | Epidermal nevus | 1.37e-04 | 4 | 142 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 1.37e-04 | 4 | 142 | 2 | cv:C0005684 | |
| Disease | Thyroid cancer, nonmedullary, 2 | 1.37e-04 | 4 | 142 | 2 | cv:C4225426 | |
| Disease | Malignant tumor of cervix | 1.37e-04 | 4 | 142 | 2 | C0007847 | |
| Disease | epidermal nevus (is_implicated_in) | 1.37e-04 | 4 | 142 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 1.37e-04 | 4 | 142 | 2 | 188470 | |
| Disease | Splenomegaly | 1.57e-04 | 22 | 142 | 3 | C0038002 | |
| Disease | LEOPARD Syndrome | 1.57e-04 | 22 | 142 | 3 | C0175704 | |
| Disease | Liver carcinoma | 1.81e-04 | 507 | 142 | 10 | C2239176 | |
| Disease | hair colour measurement | KRAS NRG1 NRAS PUM2 SIK1 RAB20 FREM2 ZNF469 MED12L CSGALNACT1 EPB41L1 | 2.00e-04 | 615 | 142 | 11 | EFO_0007822 |
| Disease | Noonan Syndrome | 2.05e-04 | 24 | 142 | 3 | C0028326 | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 2.28e-04 | 5 | 142 | 2 | C4225426 | |
| Disease | Malignant neoplasm of thyroid | 2.28e-04 | 5 | 142 | 2 | C0007115 | |
| Disease | Cetuximab response | 2.28e-04 | 5 | 142 | 2 | cv:CN077967 | |
| Disease | Cervix carcinoma | 2.28e-04 | 5 | 142 | 2 | C0302592 | |
| Disease | Panitumumab response | 2.28e-04 | 5 | 142 | 2 | cv:CN077999 | |
| Disease | carcinoma (implicated_via_orthology) | 2.61e-04 | 64 | 142 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | Autoimmune lymphoproliferative syndrome | 3.41e-04 | 6 | 142 | 2 | cv:CN301239 | |
| Disease | Carcinoma in situ of uterine cervix | 3.41e-04 | 6 | 142 | 2 | C0851140 | |
| Disease | seminoma (is_implicated_in) | 3.41e-04 | 6 | 142 | 2 | DOID:4440 (is_implicated_in) | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 3.64e-04 | 29 | 142 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.89e-04 | 71 | 142 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Malignant Neoplasms | 3.96e-04 | 128 | 142 | 5 | C0006826 | |
| Disease | Thyroid cancer, follicular | 4.75e-04 | 7 | 142 | 2 | C2931367 | |
| Disease | Rectal Neoplasms | 4.75e-04 | 7 | 142 | 2 | C0034885 | |
| Disease | Rectal Carcinoma | 4.75e-04 | 7 | 142 | 2 | C0007113 | |
| Disease | Alzheimer's disease biomarker measurement, brain volume measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0006514, EFO_0006930 | |
| Disease | peroxisomal biogenesis disorder (implicated_via_orthology) | 6.32e-04 | 8 | 142 | 2 | DOID:0080377 (implicated_via_orthology) | |
| Disease | E3 ubiquitin-protein ligase RNF13 measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0801556 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 6.60e-04 | 301 | 142 | 7 | DOID:684 (is_marker_for) | |
| Disease | Thyroid Neoplasm | 7.52e-04 | 37 | 142 | 3 | C0040136 | |
| Disease | Pancreatic carcinoma, familial | 8.10e-04 | 9 | 142 | 2 | C2931038 | |
| Disease | level of Sphingomyelin (d36:1) in blood serum | 8.10e-04 | 9 | 142 | 2 | OBA_2045178 | |
| Disease | Noonan syndrome | 8.10e-04 | 9 | 142 | 2 | cv:C0028326 | |
| Disease | heart disease (implicated_via_orthology) | 8.14e-04 | 38 | 142 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | medulloblastoma (is_implicated_in) | 1.01e-03 | 10 | 142 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 1.01e-03 | 10 | 142 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | body surface area | ILRUN ERBB3 ZBTB2 BCL2L2 MED13L SMOC2 CPED1 ATXN3 UHRF1 PLA2G6 | 1.14e-03 | 643 | 142 | 10 | EFO_0022196 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKDVPGAGEVLFMCS | 46 | A8MUN3 | |
| DKGGIEQTICMLDGV | 106 | P08243 | |
| EVDKNGLKMCEPCGG | 311 | P21860 | |
| MAEKALEAVGCGLGP | 1 | Q9H172 | |
| GGKSPLIIFSDCDMN | 256 | P49189 | |
| QEIMLSCLGEKGCEP | 1666 | Q15878 | |
| MLACTPKGDEEQLAL | 31 | Q8TDX6 | |
| GCLKEPKSSGQLMAE | 126 | Q8TDI0 | |
| LQSELKRCPSGDMKG | 711 | A4D0V7 | |
| GAALDPGCVLAKMQL | 806 | Q13085 | |
| LCAESVNKEMEPLVG | 106 | Q92843 | |
| MPDPGLVLAGTKCAD | 626 | O43184 | |
| GKAECVQSLLELGMD | 276 | Q3KP44 | |
| GDGMEQGCPKDLLAE | 366 | Q8N283 | |
| ELGCSTPLMEAAQEG | 561 | O75179 | |
| GCQFLGPAMQEEALK | 191 | Q5TC82 | |
| SDDVPMVLVGNKCDL | 106 | P01112 | |
| SEDVPMVLVGNKCDL | 106 | P01116 | |
| SDDVPMVLVGNKCDL | 106 | P01111 | |
| GALAGQEKEECSPNM | 121 | Q9NX57 | |
| TDDVPMILVGNKCDL | 106 | P61224 | |
| SGPGELQVKDMACQT | 1616 | Q9Y4B5 | |
| LPNGMDADCKDFNRT | 161 | Q8TB72 | |
| SGDKMDCVSGLSVPE | 2426 | Q14573 | |
| VNGGECFMVKDLSNP | 191 | Q02297 | |
| DVKFQAGPCGEMEDT | 656 | Q7Z304 | |
| ENCGSPAMKRVDGDV | 336 | Q6WBX8 | |
| RCMAAALKDAGVQPE | 326 | Q9NWU1 | |
| PCMVDNSGKTPLDLA | 141 | Q8WXD9 | |
| KDSEGIDIMLGVCAN | 291 | Q9H4G0 | |
| EMESLGGKCDPTQQK | 1551 | P23467 | |
| PLKGEDMAALLCQDE | 921 | A0AUZ9 | |
| KLDLGDCDLGMQSVI | 211 | Q8IZ02 | |
| GDMAGQEVLPKELLC | 3181 | Q9NU22 | |
| QCLKDPGSGSVAEMN | 1336 | Q86YW9 | |
| ELCMEQDTPGQKLGL | 496 | Q71F56 | |
| MSLLVKRGCDEGFQP | 506 | O75420 | |
| GSLPCGAKELDIMSN | 291 | Q8WWW8 | |
| ADDTMLAKDPASGIC | 1171 | P46020 | |
| MIQAADCGIGIEGKE | 881 | O43861 | |
| GPNICDGDFDTVAML | 366 | P51511 | |
| KGDLPDCEADQLLQM | 166 | P54252 | |
| NGCSELTNPEAVMGK | 691 | Q9BZQ6 | |
| GGAPETLLMDCKAFQ | 246 | Q5SZK8 | |
| AMELKPNGGADQKCL | 781 | Q8NCM2 | |
| NGIDMNAVLKGFPEC | 561 | Q9H252 | |
| EGGSVLEKLESCGPM | 211 | P41279 | |
| ISGEEACTGNPDLIM | 171 | Q32ZL2 | |
| DDNFCGLDMNAPLGV | 401 | Q9HCM2 | |
| LVEAECGGANPLMKL | 6 | P50542 | |
| TLAFNLGCDPLEMGE | 276 | Q13608 | |
| KMCSEGGLPSEMQDL | 436 | O60229 | |
| KDLLENSMLCAGIPD | 181 | P49862 | |
| MNGDLLRTLEGPENC | 2726 | P50851 | |
| MANSGCKDVTGPDEE | 1 | O75223 | |
| PDGNKIDLVCDAMRA | 811 | O95163 | |
| EQMICDTDPELGGAV | 421 | Q5MIZ7 | |
| GENGKMICSIQDDVP | 376 | Q9Y5E8 | |
| PDMLCAGDILNAKTV | 226 | A1L453 | |
| ALMALLCGDPQEKVA | 256 | Q9H579 | |
| GLRPECEQSALEGMK | 186 | Q8IZL8 | |
| PSGCEFGQADMQKLV | 961 | Q7Z6Z7 | |
| ELMLGCNALGDPTAL | 1666 | Q86WI3 | |
| IGADNACMIPGNEDK | 1886 | Q9UMZ3 | |
| KQMICDTDPELGGAV | 421 | Q6ZMV5 | |
| MDEAVGDLKQALPCV | 1 | Q15645 | |
| VCSGEGLPKADLMAF | 756 | Q9Y5I2 | |
| PGDLTVQEGKLCRMD | 1141 | Q8WX93 | |
| DRDSGENGKMICSIP | 371 | Q9Y5E5 | |
| LGMTPADDFCQGTKA | 81 | O14531 | |
| KEELENGEGVAMCPG | 36 | Q9H4G8 | |
| VDLDPELMQKFSCLG | 6 | Q9H6K1 | |
| VTGMDGGPEECKNKD | 471 | Q659A1 | |
| NCSSPADMDGIQKGL | 911 | P20023 | |
| GKPSCLNEDAMRAAD | 16 | Q7Z6I8 | |
| GIKNECEGDLAEAMP | 2751 | Q8TD57 | |
| MSEPGKGDDCLELES | 1 | Q8NFT6 | |
| FGKLVCNDENPCEGM | 1641 | Q9P0X4 | |
| AGCSEEKAKMPGNID | 571 | O15063 | |
| LKGNMGVCFDVPTTE | 626 | Q9BQ39 | |
| ACELSPKGKEQAMDL | 396 | O43303 | |
| DDMVAPFLGEGTCLQ | 291 | O75342 | |
| NKAGGPRDLKMLCAE | 311 | Q14449 | |
| GMPEGDIKALTTLCD | 231 | O95718 | |
| AAGVLAPDMSDKDKC | 1076 | Q6ZRV2 | |
| DMKPENVLLDDLGNC | 316 | Q8WTQ7 | |
| KMSCVNGTEGREELP | 211 | Q96MH7 | |
| CGMPLDSFRAKEGEQ | 426 | Q8WUM9 | |
| LLPGEDEGDQLACMI | 421 | Q92630 | |
| EMEACSNGALIPGNL | 606 | Q99661 | |
| PCRKDGLQGQLEEMT | 196 | Q53RY4 | |
| LDMKSEEGACLGPVA | 346 | Q05084 | |
| AEEPEALADGLCSMK | 421 | Q9BUB5 | |
| FLGSPCVDKLDELMG | 421 | P33402 | |
| MAKNAENEDLALGPC | 126 | Q8TC99 | |
| EKVDGALCMEKSLGP | 401 | P02790 | |
| SQKGIGMNEPLVDCE | 46 | O00233 | |
| LDCEMVGVGPKGEES | 246 | Q9GZR2 | |
| VAIPMEKGLDSQGCF | 816 | Q9Y4G2 | |
| FMADIDLDPGCTLNK | 646 | P26639 | |
| DMLSKTECGDLGSPK | 2446 | Q5T011 | |
| CGCKGPLSQEALMEL | 616 | O75691 | |
| ALGVGDVKLPCEMDA | 186 | Q9UGI8 | |
| CSTPLGMENGKIENK | 2066 | P12259 | |
| PGALEKQMSRVAGEC | 166 | Q96S42 | |
| CEPLGLLQGDCEMED | 756 | A0A0B4J2F2 | |
| CEPLGLLQGDCEMED | 756 | P57059 | |
| ELGKMVVDCCTDPDG | 726 | O60733 | |
| GLIQEMSGDASVCPD | 541 | Q92854 | |
| DPCKILVATDAIGMG | 416 | Q8IYB8 | |
| CQGGLPKEACMEISS | 516 | P40967 | |
| PKAEVDEDGVVMCSG | 1516 | Q99466 | |
| AAEKLFGNMEGDCPS | 341 | P02786 | |
| IQAGMEALKAADCPG | 561 | O94855 | |
| GAMEELEKALSCPGQ | 46 | Q15797 | |
| CPNGMEDDAIFGILN | 626 | Q8WYL5 | |
| EDDGDCQGKPSMGQL | 91 | P20062 | |
| KAGADIELGCSTPLM | 526 | Q8IWZ3 | |
| GDILAECINSAMPKG | 1721 | P25054 | |
| ELGKLGLEPGENFCM | 296 | Q70JA7 | |
| CGAKNLPSLGDNEML | 481 | Q8TBB6 | |
| TDDVPMILVGNKCDL | 106 | A6NIZ1 | |
| MSCKADVNLPQDLGD | 236 | I1YAP6 | |
| GMICKNPDLEFDSLQ | 11 | P04198 | |
| FSGIEGMVELNDCDP | 211 | P41226 | |
| VQELMGCLGVAKEDG | 406 | Q9H3U7 | |
| DGKICLVMELAEGGD | 81 | Q96PN8 | |
| LEELDLSMNPLGDGC | 1131 | Q96HA7 | |
| AEGGCCVMDELVKPE | 251 | Q96IC2 | |
| SANCLEEKGPMFELL | 46 | P10124 | |
| DLCKGKNICEGGEEM | 146 | P24928 | |
| LLNCKDDGEAMTVLG | 721 | Q6ZT07 | |
| CAGPGEMADKLLLTT | 886 | O94813 | |
| VKEECDRLGPGMADI | 226 | P07602 | |
| CIVEMGGTEKQDELG | 641 | Q15393 | |
| ACLEGEMGTSSKEPE | 2336 | Q96JG9 | |
| CGGRQDPDKQLMCDE | 321 | Q96T88 | |
| PMKRESCDAEEQSGG | 286 | Q3LFD5 | |
| KLVGFQDMECVPCGD | 126 | Q9NS68 | |
| ACKGDPAGDSMQERD | 41 | Q9Y2P0 | |
| CSNAADLGKDAMEVP | 296 | Q8N680 | |
| QGLQMDILKAEGEPC | 56 | Q9H598 | |
| PMKRESCDAEEQSGG | 286 | Q9UMW8 | |
| DVASPTQMIGDGCDL | 111 | Q2M1K9 | |
| MKEPLLGGECDKAVA | 1 | Q5SVZ6 | |
| DALCGEMPFQDSILK | 1346 | Q9C0I4 | |
| LAKGECMEDNPDSLV | 356 | Q9H9Y6 | |
| LDSLMEGGEGKLPTC | 1126 | Q9P2L0 | |
| EEAGICGLGVKADML | 41 | Q9NUQ3 | |
| MGEKSENCGVPEDLL | 1 | Q99614 | |
| KRSCDMVFGPANLGE | 1786 | Q96QT4 | |
| GHGMDLDKALEGCSP | 346 | Q6ZT21 | |
| AEMGKPVLGENCRLE | 646 | Q9UPR5 |